tiprankstipranks
Trending News
More News >
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Income Statement

Compare
607 Followers

Adial Pharmaceuticals Income Statement

Last quarter (Q4 2025), Adial Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Adial Pharmaceuticals's net income was $-2.00M. See Adial Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -565.00$ 0.00$ -564.00$ 0.00$ 0.00
Operating Expenses
$ 7.80M$ 8.28M$ 6.89M$ 10.86M$ 19.29M
Depreciation and Amortization
$ 565.00$ 565.00$ 564.00$ 564.00$ 55.11K
EBITDA
$ -7.80M$ -8.28M$ -7.00M$ -10.86M$ -17.69M
Operating Income
$ -7.80M$ -8.28M$ -6.89M$ -10.86M$ -19.29M
Other Income/Expenses
$ -177.71K$ -4.91M$ -113.94K$ 63.34K$ -228.68K
Pretax Income
$ -7.98M$ -13.20M$ -7.00M$ -10.80M$ -19.52M
Net Income
$ -7.98M$ -13.20M$ -7.00M$ -12.73M$ -19.42M
Per Share Metrics
Basic EPS
$ -11.93$ -17.75$ -136.00$ -299.50$ -653.00
Diluted EPS
$ -11.93$ -17.75$ -136.00$ -299.50$ -653.00
Weighted Average Shares Outstanding
668.63K 743.55K 56.99K 42.52K 29.74K
Weighted Average Shares Outstanding (Diluted)
668.63K 743.55K 56.99K 42.52K 29.74K
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History